Cohesion's CoStasis Surgical Hemostat To Ship In July, Gains FDA Approval
This article was originally published in The Gray Sheet
Tyco International's U.S. Surgical unit will market Cohesion Technologies' CoStasis liquid surgical hemostat. Shipments are expected to begin in early July.
You may also be interested in...
Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.
Cohesion Technologies plans to file a premarket approval application this spring for its CoStasis surgical hemostat for treatment of bleeding in cardiovascular, hepatic, general and orthopedic surgery procedures, the firm announced Jan. 14.
The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.